139 related articles for article (PubMed ID: 21297379)
1. Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation.
Moon MH; Jeong JK; Seo JS; Seol JW; Lee YJ; Xue M; Jackson CJ; Park SY
Exp Mol Med; 2011 Mar; 43(3):138-45. PubMed ID: 21297379
[TBL] [Abstract][Full Text] [Related]
2. Chrysanthemulide A induces apoptosis through DR5 upregulation via JNK-mediated autophagosome accumulation in human osteosarcoma cells.
Zhuo FF; Zhang C; Zhang H; Xia Y; Xue GM; Yang L; Kong LY
J Cell Physiol; 2019 Aug; 234(8):13191-13208. PubMed ID: 30556589
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells.
Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
Biochem Biophys Res Commun; 2013 Sep; 439(2):179-86. PubMed ID: 23994633
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole.
Goda AE; Yoshida T; Horinaka M; Yasuda T; Shiraishi T; Wakada M; Sakai T
Oncogene; 2008 May; 27(24):3435-45. PubMed ID: 18193086
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells.
Matsui TA; Sowa Y; Yoshida T; Murata H; Horinaka M; Wakada M; Nakanishi R; Sakabe T; Kubo T; Sakai T
Carcinogenesis; 2006 Sep; 27(9):1768-77. PubMed ID: 16571651
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
[TBL] [Abstract][Full Text] [Related]
8. Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells.
Hori T; Kondo T; Kanamori M; Tabuchi Y; Ogawa R; Zhao QL; Ahmed K; Yasuda T; Seki S; Suzuki K; Kimura T
J Orthop Res; 2010 Jun; 28(6):739-45. PubMed ID: 20041491
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation.
Sonnemann J; Trommer N; Becker S; Wittig S; Grauel D; Palani CD; Beck JF
Cancer Biol Ther; 2012 Apr; 13(6):417-24. PubMed ID: 22313685
[TBL] [Abstract][Full Text] [Related]
10. Correlation between TRAIL and caspase-8 expression and their relationship with cell proliferation and apoptosis in human osteosarcoma.
Ning X; Shang XW; Zhuang Y; Liu M; Yang H; Zhang H; Huang MZ
Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002586
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.
Cenni V; Maraldi NM; Ruggeri A; Secchiero P; Del Coco R; De Pol A; Cocco L; Marmiroli S
Int J Oncol; 2004 Dec; 25(6):1599-608. PubMed ID: 15547696
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of c-FLIP by RNAi enhances sensitivity of the human osteogenic sarcoma cell line U2OS to TRAIL-induced apoptosis.
Zhang YP; Kong QH; Huang Y; Wang GL; Chang KJ
Asian Pac J Cancer Prev; 2015; 16(6):2251-6. PubMed ID: 25824746
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
[TBL] [Abstract][Full Text] [Related]
15. TRAIL responses are enhanced by nuclear export inhibition in osteosarcoma.
Phillips KL; Wright N; McDermott E; Cross NA
Biochem Biophys Res Commun; 2019 Sep; 517(2):383-389. PubMed ID: 31362889
[TBL] [Abstract][Full Text] [Related]
16. LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcoma.
Takeda S; Iwai A; Nakashima M; Fujikura D; Chiba S; Li HM; Uehara J; Kawaguchi S; Kaya M; Nagoya S; Wada T; Yuan J; Rayter S; Ashworth A; Reed JC; Yamashita T; Uede T; Miyazaki T
Anticancer Res; 2007; 27(2):761-8. PubMed ID: 17465200
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial Ca2+ removal amplifies TRAIL cytotoxicity toward apoptosis-resistant tumor cells via promotion of multiple cell death modalities.
Takata N; Ohshima Y; Suzuki-Karasaki M; Yoshida Y; Tokuhashi Y; Suzuki-Karasaki Y
Int J Oncol; 2017 Jul; 51(1):193-203. PubMed ID: 28560396
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-661 Enhances TRAIL or STS Induced Osteosarcoma Cell Apoptosis by Modulating the Expression of Cytochrome c1.
Fan L; Zhu C; Qiu R; Zan P; Zheng Z; Xu T; Li G
Cell Physiol Biochem; 2017; 41(5):1935-1946. PubMed ID: 28391262
[TBL] [Abstract][Full Text] [Related]
20. Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.
Zhou L; Wang W; Dicker DT; Humphreys RC; El-Deiry WS
Cancer Biol Ther; 2011 Aug; 12(4):335-48. PubMed ID: 21785270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
